{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:08:38Z","timestamp":1790219318803,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cbi.2019.04.022","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:12:11Z","timestamp":1555542731000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia"],"prefix":"10.1016","volume":"306","author":[{"given":"Sushil Kumar","family":"Sah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Paul","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu M.","family":"Gilhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gubbiyappa Shiva","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaraja","family":"SreeHarsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.04.022_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2019.04.022_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41574-018-0097-y","article-title":"The \u03b1-cell in diabetes mellitus","volume":"14","author":"Gromada","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cbi.2019.04.022_bib3","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1073\/pnas.1006639107","article-title":"Paracrinology of islets and the paracrinopathy of diabetes","volume":"107","author":"Unger","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2019.04.022_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/BF00400591","article-title":"Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?","volume":"38","author":"Cerasi","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2019.04.022_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality","volume":"52","author":"Kahn","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2019.04.022_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2019.04.022_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1073\/pnas.73.4.1338","article-title":"Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes","volume":"73","author":"Orci","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2019.04.022_bib8","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017019457","article-title":"Nephrotoxicity in rats exposed to paracetamol: the protective role of moralbosteroid, a steroidal glycoside","volume":"36","author":"Gupta","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cbi.2019.04.022_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.fitote.2011.10.004","article-title":"Anti-diabetic potential of ursolic acid stearoyl glucoside: a new triterpenic gycosidic ester from Lantana camara","volume":"83","author":"Kazmi","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2019.04.022_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/er.2006-0026","article-title":"The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications","volume":"28","author":"Dunning","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2019.04.022_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2006-0007","article-title":"Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains","volume":"28","author":"Gromada","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2019.04.022_bib12","first-page":"31","article-title":"Control of hepatic glucose output by glucagon and insulin in the intact dog","author":"Cherrington","year":"1978","journal-title":"Biochemical Society symposium"},{"key":"10.1016\/j.cbi.2019.04.022_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diab.26.11.1040","article-title":"The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs","volume":"26","author":"Keller","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2019.04.022_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2015.39.1.1","article-title":"Pancreatic \u03b1-cell dysfunction in type 2 diabetes: old kids on the block","volume":"39","author":"Moon","year":"2015","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.cbi.2019.04.022_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.23736\/S0031-0808.18.03394-3","article-title":"A clinical update on metformin and lung cancer in diabetic patients","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2019.04.022_bib16","first-page":"87","article-title":"Nanotechnology and diabetic wound healing: a review, endocrine, metabolic & immune disorders-drug targets (formerly current drug targets-immune","volume":"17","author":"Kumar Chellappan","year":"2017","journal-title":"Endocrine & Metabolic Disorders)"},{"key":"10.1016\/j.cbi.2019.04.022_bib17","first-page":"329","article-title":"Cognitive function in patients with diabetes mellitus: guidance for daily care, the Lancet","volume":"14","author":"Koekkoek","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2019.04.022_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cbi.2019.04.022_bib19","first-page":"P179","article-title":"Type 1 diabetes and risk of dementia in late life: the kaiser diabetes & cognitive aging study, Alzheimer's & Dementia","volume":"11","author":"Whitmer","year":"2015","journal-title":"The Journal of the Alzheimer's Association"},{"key":"10.1016\/j.cbi.2019.04.022_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2337\/ds16-0050","article-title":"Cognition in adults and older adults with type 1 diabetes: chicken or egg?","volume":"29","author":"Chaytor","year":"2016","journal-title":"Diabetes Spectr. : a publication of the American Diabetes Association"},{"key":"10.1016\/j.cbi.2019.04.022_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S1355617713001434","article-title":"Cognitive functioning in young children with type 1 diabetes","volume":"20","author":"Cato","year":"2014","journal-title":"J. Int. Neuropsychol. Soc. : JINS"},{"key":"10.1016\/j.cbi.2019.04.022_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.diabet.2014.02.002","article-title":"Update on cognitive decline and dementia in elderly patients with diabetes","volume":"40","author":"Bordier","year":"2014","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cbi.2019.04.022_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1464-5491.2011.03505.x","article-title":"Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetic medicine","volume":"29","author":"Aung","year":"2012","journal-title":"a journal of the British Diabetic Association"},{"key":"10.1016\/j.cbi.2019.04.022_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/CIA.S48926","article-title":"Type 2 diabetes as a risk factor for cognitive impairment: current insights","volume":"9","author":"Umegaki","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.cbi.2019.04.022_bib25","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017020182","article-title":"Oral insulin: current status, challenges, and future perspectives","volume":"36","author":"Chellappan","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cbi.2019.04.022_bib26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/13803390490514875","article-title":"The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function","volume":"26","author":"Awad","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.cbi.2019.04.022_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","article-title":"Type 2 diabetes mellitus, cognitive impairment and dementia, Diabetic medicine","volume":"16","author":"Stewart","year":"1999","journal-title":"a journal of the British Diabetic Association"},{"key":"10.1016\/j.cbi.2019.04.022_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2337\/diacare.20.3.438","article-title":"Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies","volume":"20","author":"Strachan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2019.04.022_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbr.2014.08.033","article-title":"Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio)","volume":"274","author":"Capiotti","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.04.022_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1423-0127-16-38","article-title":"Enhanced muscarinic M1 receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats","volume":"16","author":"Gireesh","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.cbi.2019.04.022_bib31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","article-title":"Gene therapy and type 1 diabetes mellitus","volume":"108","author":"Chellappan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.04.022_bib32","first-page":"28","article-title":"Embarking effect of ACE2-angiotensin 1\u20137\/mas receptor Axis in benign prostate hyperplasia","author":"Singh","year":"2018","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.cbi.2019.04.022_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbr.2014.08.033","article-title":"Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio)","volume":"274","author":"Capiotti","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.04.022_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabres.2005.08.009","article-title":"Serum cholinesterase activity in diabetes and associated pathologies","volume":"72","author":"Inacio Lunkes","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2019.04.022_bib35","first-page":"75","article-title":"Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review, the lancet","volume":"3","author":"Geijselaers","year":"2015","journal-title":"Diabetes & endocrinology"},{"key":"10.1016\/j.cbi.2019.04.022_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2019.04.022_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-5491.2010.03199.x","article-title":"The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia","volume":"28","author":"Strachan","year":"2010","journal-title":"Diabet. Med. : a journal of the British Diabetic Association"},{"key":"10.1016\/j.cbi.2019.04.022_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.23736\/S0031-0808.18.03455-9","article-title":"Current therapies and targets for type 2 diabetes mellitus","volume":"60","author":"Chellappan","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2019.04.022_bib39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2017.02.048","article-title":"Pharmacological evaluation of aqueous extract of syzigium cumini for its antihyperglycemic and antidyslipidemic properties in diabetic rats fed a high cholesterol diet\u2014role of PPAR\u03b3 and PPAR\u03b1","volume":"89","author":"Sharma","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.04.022_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","article-title":"The role of type 2 diabetes in neurodegeneration","volume":"84","author":"Verdile","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cbi.2019.04.022_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J. Alzheimer's Dis. : JAD"},{"key":"10.1016\/j.cbi.2019.04.022_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2019.04.022_bib43","doi-asserted-by":"crossref","first-page":"102158","DOI":"10.1155\/2014\/102158","article-title":"Diabetes and the brain: oxidative stress, inflammation, and autophagy","volume":"2014","author":"Muriach","year":"2014","journal-title":"Oxidative medicine and cellular longevity"},{"key":"10.1016\/j.cbi.2019.04.022_bib44","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s12035-018-1195-5","article-title":"Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models","volume":"56","author":"Rom","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cbi.2019.04.022_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","article-title":"Diabetes mellitus and dementia","volume":"14","author":"Ninomiya","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.cbi.2019.04.022_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db16-0917","article-title":"Brain GLUT4 knockout mice have impaired glucose tolerance, decreased insulin sensitivity, and impaired hypoglycemic counterregulation","volume":"66","author":"Reno","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2019.04.022_bib47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.dsx.2018.05.003","article-title":"Thinking about brain insulin resistance","volume":"12","author":"Al Haj Ahmad","year":"2018","journal-title":"Diabetes & metabolic syndrome"},{"key":"10.1016\/j.cbi.2019.04.022_bib48","first-page":"752","article-title":"Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures","volume":"16","author":"Gupta","year":"2017","journal-title":"EXCLI journal"},{"key":"10.1016\/j.cbi.2019.04.022_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2018.04.007","article-title":"Evidence for gastroprotective, anti-inflammatory and antioxidant potential of methanolic extract of Cordia dichotoma leaves on indomethacin and stress induced gastric lesions in Wistar rats","volume":"103","author":"Hatware","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.04.022_bib50","first-page":"289","article-title":"The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease","volume":"47","author":"Armstrong","year":"2009","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.cbi.2019.04.022_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biomag.2013.10.005","article-title":"Anticonvulsant activity of Morusin isolated from Morus alba: modulation of GABA receptor","volume":"4","author":"Gupta","year":"2014","journal-title":"Biomedicine & Aging Pathology"},{"key":"10.1016\/j.cbi.2019.04.022_bib52","first-page":"211","article-title":"Recent updates on neuropharmacological effects of luteolin","volume":"17","author":"Gupta","year":"2018","journal-title":"EXCLI Journal"},{"issue":"Suppl 4","key":"10.1016\/j.cbi.2019.04.022_bib53","doi-asserted-by":"crossref","first-page":"S575","DOI":"10.3233\/JAD-141284","article-title":"Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline","volume":"42","author":"O'Caoimh","year":"2014","journal-title":"J. Alzheimer's Dis. : JAD"},{"key":"10.1016\/j.cbi.2019.04.022_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/VHRM.S1905","article-title":"The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.cbi.2019.04.022_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"ON THE RELATION OF CHRONIC INTERSTITIAL PANCREATITIS TO THE ISLANDS OF LANGERHANS AND TO DIABETES MELUTUS","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2019.04.022_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2019.04.022_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13212-4","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2019.04.022_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2019.04.022_bib60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2012.03.013","article-title":"Sedative, antiepileptic and antipsychotic effects of Viscum album L.(Loranthaceae) in mice and rats","volume":"141","author":"Gupta","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.23736\/S0031-0808.18.03462-6","article-title":"Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2019.04.022_bib62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"issue":"Suppl 3","key":"10.1016\/j.cbi.2019.04.022_bib63","doi-asserted-by":"crossref","first-page":"105s","DOI":"10.1177\/0145721706288S246","article-title":"Amylin replacement therapy in patients with insulin-requiring type 2 diabetes","volume":"32","author":"Owen","year":"2006","journal-title":"Diabetes Educat."},{"key":"10.1016\/j.cbi.2019.04.022_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/13892037113149990050","article-title":"Islet amyloid polypeptide and diabetes","volume":"14","author":"Westermark","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.cbi.2019.04.022_bib65","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2019.04.022_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11010-014-2064-9","article-title":"Protective effect of pioglitazone, a PPAR\u03b3 agonist against acetaminophen-induced hepatotoxicity in rats","volume":"393","author":"Gupta","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2019.04.022_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12026-017-8956-5","article-title":"Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes","volume":"66","author":"Zhang","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cbi.2019.04.022_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/cns.12137","article-title":"Effect of R osiglitazone, a PPAR\u2010\u03b3 Ligand on H aloperidol\u2010I nduced C atalepsy","volume":"19","author":"Gupta","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2019.04.022_bib69","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc07-2446","article-title":"Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide","volume":"31","author":"Woerle","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2019.04.022_bib70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13212-4","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib71","series-title":"The Calcitonin Gene-Related Peptide Family: Form, Function and Future Perspectives","author":"Hay","year":"2010"},{"key":"10.1016\/j.cbi.2019.04.022_bib72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2019.04.022_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/head.13077","article-title":"Amylin, headache","volume":"57","author":"Hay","year":"2017","journal-title":"The Journal of Head and Face Pain"},{"key":"10.1016\/j.cbi.2019.04.022_bib74","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1476-5381.2011.01571.x","article-title":"Consequences of splice variation on Secretin family G protein-coupled receptor function","volume":"166","author":"Furness","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.04.022_bib76","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib77","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2012.02197.x","article-title":"Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Delta(1-47)hCT((a)) function","volume":"168","author":"Qi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","article-title":"Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes","volume":"166","author":"Bailey","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib79","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.peptides.2010.03.027","article-title":"A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor","volume":"31","author":"Gingell","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.cbi.2019.04.022_bib80","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/mol.108.047142","article-title":"Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function","volume":"74","author":"Qi","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.022_bib81","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diabetes.39.7.875","article-title":"Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes","volume":"39","author":"Morishita","year":"1990","journal-title":"Diabetes"},{"issue":"Pt 1","key":"10.1016\/j.cbi.2019.04.022_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj2770139","article-title":"Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes","volume":"277","author":"Chantry","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.04.022_bib83","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0006-291X(91)91855-7","article-title":"Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors","volume":"177","author":"Zhu","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2019.04.022_bib84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0196-9781(91)90106-Y","article-title":"Islet amyloid polypeptide (IAPP) competes for two binding sites of CGRP","volume":"12","author":"Galeazza","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.cbi.2019.04.022_bib85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(00)89093-8","article-title":"Pharmacology of receptors for calcitonin gene-related peptide and amylin","volume":"16","author":"Poyner","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2019.04.022_bib86","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","article-title":"Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro","volume":"335","author":"Leighton","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2019.04.022_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0168-8227(92)90068-3","article-title":"Islet amyloid polypeptide (IAPP\/amylin) causes insulin resistance in perfused rat hindlimb muscle","volume":"15","author":"Tabata","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2019.04.022_bib88","series-title":"Handbook of Biologically Active Peptides","first-page":"744","article-title":"Chapter 100 - CGRP\/adrenomedullin","author":"Wootten","year":"2013"},{"key":"10.1016\/j.cbi.2019.04.022_bib89","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.biopha.2017.10.058","article-title":"The role of pazopanib on tumour angiogenesis and in the management of cancers: a review","volume":"96","author":"Chellappan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.04.022_bib90","first-page":"742","article-title":"Recent update on biological activities and pharmacological actions of liraglutide","volume":"16","author":"Tiwari","year":"2017","journal-title":"EXCLI journal"},{"key":"10.1016\/j.cbi.2019.04.022_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02885531","article-title":"Evidence that CGRP and cAMP increase transcription of AChR alpha-subunit gene, but not of other subunit genes","volume":"3","author":"Moss","year":"1991","journal-title":"J. Mol. Neurosci. : M"},{"key":"10.1016\/j.cbi.2019.04.022_bib92","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/bi901848m","article-title":"Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor","volume":"49","author":"Koth","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2019.04.022_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0891-0618(00)00112-5","article-title":"Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography","volume":"20","author":"Chai","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.cbi.2019.04.022_bib94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jsps.2012.05.012","article-title":"Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in rats","volume":"20","author":"Afzal","year":"2012","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.cbi.2019.04.022_bib95","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11892-019-1144-3","article-title":"Current status on immunological therapies for type 1 diabetes mellitus","volume":"19","author":"Xin","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.cbi.2019.04.022_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pneurobio.2004.03.003","article-title":"The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory","volume":"72","author":"Wright","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.cbi.2019.04.022_bib97","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1159\/000212099","article-title":"Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis","volume":"9","author":"Schneider","year":"2009","journal-title":"Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]"},{"key":"10.1016\/j.cbi.2019.04.022_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.athoracsur.2010.03.063","article-title":"Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease","volume":"90","author":"Zhang","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.cbi.2019.04.022_bib99","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.108.147280","article-title":"Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus","volume":"330","author":"Narimatsu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.04.022_bib100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopha.2009.06.009","article-title":"Calcitonin gene-related peptide enhances CREB phosphorylation and attenuates tau protein phosphorylation in rat brain during focal cerebral ischemia\/reperfusion","volume":"64","author":"Zhang","year":"2010","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.cbi.2019.04.022_bib101","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2019.04.022_bib102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-5448.2008.00490.x","article-title":"Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus","volume":"10","author":"Hassan","year":"2009","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cbi.2019.04.022_bib103","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1210\/jc.2008-2580","article-title":"Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia","volume":"94","author":"Heptulla","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2019.04.022_bib104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874104501105010078","article-title":"Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function","volume":"5","author":"Adeghate","year":"2011","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.cbi.2019.04.022_bib105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/14746514050050030701","article-title":"Amylin analogue as an antidiabetic agent","volume":"5","author":"Day","year":"2005","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"10.1016\/j.cbi.2019.04.022_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0167-0115(88)90419-3","article-title":"Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide","volume":"23","author":"Pettersson","year":"1988","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cbi.2019.04.022_bib107","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12031-018-1202-3","article-title":"An intraperitoneal treatment with calcitonin gene-related peptide (CGRP) regulates appetite, energy intake\/expenditure, and metabolism","volume":"67","author":"Sanford","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2019.04.022_bib108","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","article-title":"Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue","volume":"18","author":"Kolterman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2019.04.022_bib109","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2019.04.022_bib110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2019.04.022_bib111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2982.2002.00311.x","article-title":"Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus","volume":"14","author":"Vella","year":"2002","journal-title":"Neuro Gastroenterol. Motil. : the official journal of the European Gastrointestinal Motility Society"},{"key":"10.1016\/j.cbi.2019.04.022_bib112","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2019.04.022_bib113","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"10.1016\/j.cbi.2019.04.022_bib114","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.cbi.2019.04.022_bib115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10620-018-5345-4","article-title":"Protective effects of calcitonin gene-related peptide-mediated p38 mitogen-activated protein kinase pathway on severe acute pancreatitis in rats","volume":"64","author":"Hu","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cbi.2019.04.022_bib116","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cns.12696","article-title":"Calcitonin gene-related peptide (CGRP): a novel target for Alzheimer's disease","volume":"23","author":"Singh","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2019.04.022_bib117","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-140210","article-title":"Positive association between plasma amylin and cognition in a homebound elderly population","volume":"42","author":"Qiu","year":"2014","journal-title":"J. Alzheimer's Dis. : JAD"},{"key":"10.1016\/j.cbi.2019.04.022_bib118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","article-title":"Molecular links between Alzheimer's disease and diabetes mellitus","volume":"250","author":"Yang","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2019.04.022_bib119","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719304806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719304806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:54:24Z","timestamp":1757858064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719304806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":119,"alternative-id":["S0009279719304806"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.022","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}